Provided by Tiger Fintech (Singapore) Pte. Ltd.

AstraZeneca PLC

75.58
+1.341.81%
Volume:4.61M
Turnover:346.76M
Market Cap:234.39B
PE:33.59
High:75.78
Open:75.21
Low:74.69
Close:74.24
Loading ...

Here's Why Astrazeneca (AZN) is a Strong Value Stock

Zacks
·
29 Jan

RFK Jr. Goes to Capitol Hill. His Record Jeopardizes HHS Nomination. -- Barrons.com

Dow Jones
·
29 Jan

FDA Expands Label of AZN's Enhertu for New Breast Cancer Indication

Zacks
·
29 Jan

Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday

MT Newswires Live
·
28 Jan

AstraZeneca, Daiichi Sankyo's Enhertu Gets US FDA Approval for Treatment of Inoperable Breast Cancers

MT Newswires Live
·
28 Jan

Berenberg Bank Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
28 Jan

AstraZeneca Receives FDA Approval for Enhertu Breast Cancer Treatment

Dow Jones
·
28 Jan

Enhertu approved in the US as HER2-directed therapy

TIPRANKS
·
28 Jan

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

Business Wire
·
28 Jan

AstraZeneca PLC ADR Rises Monday, Outperforms Market

Dow Jones
·
28 Jan

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
28 Jan

European Pharma Companies to Report 4Q Results With U.S Policy Uncertainty in Focus -- Sector Preview

Dow Jones
·
27 Jan

Pharma Stock Roundup: JNJ's Q4 Earnings, FDA Nod to AZN, Daiichi Drug

Zacks
·
25 Jan

AstraZeneca PLC Stock Rises Friday, Underperforms Market

Dow Jones
·
25 Jan

Here's Why Astrazeneca (AZN) is a Strong Growth Stock

Zacks
·
24 Jan

Astrazeneca to Invest $570 Million in Canadian Operations

MT Newswires Live
·
24 Jan